Does semaglutide show up in regular blood work?

Step 1: understand what routine blood work actually looks for

When your GP requests a routine blood test, the panel typically covers a set of physiological markers: full blood count, urea and electrolytes, liver function tests, fasting glucose or HbA1c, lipid profile and sometimes thyroid function. What it does not include is a screen for which medicines are circulating in your blood. Detecting a specific drug requires a separate, purpose-built assay, and no routine NHS or private wellness panel runs one for semaglutide.

This is a point worth clearing up gently, because a lot of people worry their GP will somehow 'catch' them taking a weight-loss medicine. That is not how blood panels work. Your GP sees glucose, not semaglutide. They see ALT, not Wegovy. The medicine itself is invisible to standard lab equipment.

If you want to read more about how semaglutide behaves chemically, the semaglutide overview on this site covers the mechanism in plain terms. The NHS medicines page for semaglutide also sets out what monitoring is and is not required during treatment.

Step 2: recognise the markers semaglutide does change

Just because the medicine itself is undetectable does not mean blood work stays static. Semaglutide acts on GLP-1 receptors involved in glucose regulation and appetite, and that activity shows up indirectly in the numbers your GP does track.

The most consistent changes seen in clinical studies include reductions in fasting blood glucose and HbA1c (particularly relevant for people with prediabetes or type 2 diabetes) and falls in triglyceride levels. Some people also see modest improvements in LDL cholesterol. These are generally positive shifts, but they can prompt questions from a GP who does not know you are on treatment.

There is also the question of how semaglutide affects blood work more broadly, including liver enzymes, which sometimes fluctuate in the early months of significant weight change rather than from the medicine directly. If your ALT creeps up and then settles as your weight stabilises, that pattern is recognisable to a clinician familiar with GLP-1 treatments.

The glucose-regulation question gets its own dedicated answer if blood sugar is the specific thing you are monitoring.

Step 3: know what to tell your GP and what to ask your prescriber

Transparency with your GP is straightforwardly sensible. If you are taking a prescription medicine for weight management and your GP orders blood tests, telling them avoids unnecessary follow-up. A result that looks puzzling in isolation (a lower HbA1c, a changed lipid picture) makes immediate sense once they know the context.

The NHS guidance on semaglutide notes that routine monitoring requirements are not mandatory for all patients, but your individual clinical situation may mean your prescriber wants periodic checks. That is a conversation worth having.

At nume, a real prescriber reviews your consultation personally before any treatment is approved or continued. Questions about your blood results (whether from a recent GP visit or a private check) are exactly the kind of thing to raise during that review. Our clinical team can advise on what your numbers mean in the context of semaglutide treatment, and our FAQs cover some of the monitoring questions patients ask most often.

If you are thinking about what Wegovy treatment involves from a practical and financial standpoint, the Wegovy pricing page lays out what is included at each stage, consultation, prescription and aftercare in one place, with no separate monitoring fees added on.

Step 4: what to do if a blood result concerns you

Any unexpected result deserves a direct conversation rather than an internet search. If your GP flags something and you are on semaglutide, the most useful thing is to connect both pieces of information: tell the GP what you are taking, and let your prescriber know what the GP found.

Acute pancreatitis is a rare but serious risk with GLP-1 medicines, the MHRA issued a Drug Safety Update in January 2026 reinforcing this. It does not show up in routine blood work as a regular monitor, but severe or persistent stomach pain, especially pain that reaches through to your back, should prompt urgent medical attention rather than a phone call to your prescriber. The MHRA's Yellow Card scheme is available for reporting any suspected side effects.

For people curious about the broader picture of what blood tests can and cannot show, the routine blood work question and the related blood test detection page each dig into specific angles of this topic. And if you are at the stage of considering treatment, the free consultation is the right starting point, a prescriber reviews your full health picture before anything is approved.